Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Graft-versus-host disease | R-HSA-1643685 | map05332 | pyrazinamide | 1046 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | pyrazinamide | 1046 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | pyrazinamide | 1046 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | pyrazinamide | 1046 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | pyrazinamide | 1046 | drug-path |
Asthma | R-HSA-444620 | map05310 | pyrazinamide | 1046 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | pyrazinamide | 1046 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | pyrazinamide | 1046 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | pyrazinamide | 1046 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | pyrazinamide | 1046 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tiabendazole | 4075 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tiabendazole | 4075 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | tiabendazole | 4075 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | tiabendazole | 4075 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | tiabendazole | 4075 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | tiabendazole | 4075 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | propylthiouracil | 657298 | drug-path |
Wnt signaling pathway | R-HSA-195721 | map04310 | propylthiouracil | 657298 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | propylthiouracil | 657298 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | propylthiouracil | 657298 | drug-path |